BR9609857A - Composições de paroxetina de liberação controlada - Google Patents

Composições de paroxetina de liberação controlada

Info

Publication number: BR9609857A
Authority: BR; Brazil
Prior art keywords: controlled; paroxetine compositions; release paroxetine; release; compositions
Prior art date: 1995-07-20

Application number

BR9609857A

Other languages

English (en)

Inventor

Graham Stanley Leonard

David Philip Edler

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-20

Filing date

1996-07-19

Publication date

1999-03-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10777960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9609857(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-19 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-03-16 Publication of BR9609857A publication Critical patent/BR9609857A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Polyurethanes Or Polyureas (AREA)

BR9609857A 1995-07-20 1996-07-19 Composições de paroxetina de liberação controlada BR9609857A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9514842.5A GB9514842D0 (en)	1995-07-20	1995-07-20	Novel formulation
PCT/EP1996/003252 WO1997003670A1 (en)	1995-07-20	1996-07-19	Paroxetine controlled release compositions

Publications (1)

Publication Number	Publication Date
BR9609857A true BR9609857A (pt)	1999-03-16

Family

ID=10777960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9609857A BR9609857A (pt)	1995-07-20	1996-07-19	Composições de paroxetina de liberação controlada

Country Status (40)

Country	Link
EP (2)	EP0839039B2 (pt)
JP (2)	JP3922392B2 (pt)
KR (1)	KR100468351B1 (pt)
CN (2)	CN1282456C (pt)
AP (1)	AP1052A (pt)
AR (1)	AR003463A1 (pt)
AT (1)	ATE253361T1 (pt)
AU (1)	AU6659196A (pt)
BG (1)	BG64076B1 (pt)
BR (1)	BR9609857A (pt)
CA (2)	CA2227298C (pt)
CY (1)	CY2408B1 (pt)
CZ (1)	CZ294110B6 (pt)
DE (1)	DE69630603T3 (pt)
DK (1)	DK0839039T4 (pt)
DZ (1)	DZ2074A1 (pt)
EA (2)	EA003508B1 (pt)
EG (1)	EG23934A (pt)
ES (1)	ES2208757T5 (pt)
GB (1)	GB9514842D0 (pt)
HU (1)	HU228853B1 (pt)
IL (1)	IL122940A0 (pt)
MA (1)	MA23942A1 (pt)
MX (1)	MX9800571A (pt)
MY (1)	MY141373A (pt)
NO (1)	NO315637B1 (pt)
NZ (1)	NZ315006A (pt)
OA (1)	OA10652A (pt)
PE (1)	PE16098A1 (pt)
PL (1)	PL184987B1 (pt)
PT (1)	PT839039E (pt)
RO (1)	RO119119B1 (pt)
SI (1)	SI0839039T2 (pt)
SK (1)	SK284117B6 (pt)
TR (1)	TR199800077T1 (pt)
TW (1)	TW464513B (pt)
UA (1)	UA68328C2 (pt)
UY (3)	UY24288A1 (pt)
WO (1)	WO1997003670A1 (pt)
ZA (1)	ZA966148B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US5910319A (en) *	1997-05-29	1999-06-08	Eli Lilly And Company	Fluoxetine enteric pellets and methods for their preparation and use
WO1998056787A1 (en)	1997-06-10	1998-12-17	Synthon B.V.	4-Phenylpiperidine compounds
US5955475A (en) *	1997-06-30	1999-09-21	Endo Pharmaceuticals Inc.	Process for manufacturing paroxetine solid dispersions
NZ513456A (en)	1997-07-01	2003-02-28	Pfizer	Sertraline acetate, L-lactate and L-aspartate, processes for their preparation and their uses in psychotic disorders
GB9808479D0 (en) *	1998-04-22	1998-06-17	Smithkline Beecham Plc	Method of treatment
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US6139875A (en) *	1998-09-29	2000-10-31	Eastman Chemical Company	Aqueous enteric coating composition and low gastric permeability enteric coating
DE50011819D1 (de)	1999-03-12	2006-01-12	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
SK286865B6 (sk) *	1999-05-20	2009-06-05	Elan Pharma International Limited	Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
WO2000078290A2 (en) *	1999-06-22	2000-12-28	Smithkline Beecham P.L.C.	Pharmaceutical composition comprising a salt of paroxetine
ES2162560B1 (es) *	1999-06-25	2002-07-16	Rodriguez Concepcion Pena	Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
AR030557A1 (es)	2000-04-14	2003-08-27	Jagotec Ag	Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6482440B2 (en) *	2000-09-21	2002-11-19	Phase 2 Discovery, Inc.	Long acting antidepressant microparticles
WO2003013480A1 (en) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Improved enteric formulation of fluoxetin
GB2392385A (en) *	2002-09-02	2004-03-03	Cipla Ltd	Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
CN1874767A (zh)	2003-10-29	2006-12-06	惠氏公司	包含aplindore和其衍生物的缓释药物组合物
WO2005079756A2 (en) *	2004-02-13	2005-09-01	Neuromolecular, Inc.	Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
WO2005107716A1 (en) *	2004-03-25	2005-11-17	Cadila Healthcare Limited	Controlled release paroxetine-containing tablets based on a core and a coating
WO2007015270A2 (en) *	2005-08-02	2007-02-08	Lupin Limited	Novel controlled release compositions of selective serotonin reuptake inhibitors
KR100591142B1 (ko) *	2005-11-04	2006-06-20	지엘팜텍 주식회사	파록세틴을 활성물질로 함유하는 장용성 서방형 정제
WO2007132344A2 (en) *	2006-05-09	2007-11-22	Aurobindo Pharma Limited	Controlled release compositions of an antidepressant agent
KR100885029B1 (ko) *	2007-02-07	2009-02-23	지엘팜텍 주식회사	경구투여용 서방성 삼중정제
WO2009006299A2 (en) *	2007-06-29	2009-01-08	Dr. Reddy's Laboratories Ltd.	Multi-particulate systems
EP2200997B9 (en)	2007-09-13	2016-01-13	Concert Pharmaceuticals Inc.	Synthesis of deuterated benzodioxoles
TW201010743A (en)	2008-09-05	2010-03-16	Otsuka Pharma Co Ltd	Pharmaceutical solid preparation
KR20120065328A (ko) *	2009-08-24	2012-06-20	하. 룬드벡 아크티에셀스카브	１-［２-（２,４-디메틸-페닐술파닐）-페닐］피페라진의 신규한 조성물
CN103371982A (zh) *	2012-04-20	2013-10-30	王进京	盐酸帕罗西汀肠溶控释片新型处方组成及制备方法
JP2015522047A (ja) *	2012-07-09	2015-08-03	ユニリーバー・ナームローゼ・ベンノートシヤープ	光保護パーソナルケア組成物
CN103550182B (zh) *	2013-10-29	2015-04-08	吉林省东盟制药有限公司	一种肠溶缓释组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
MC2025A1 (fr) *	1988-04-20	1990-04-25	Asta Pharma Ag	Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IT1237904B (it) *	1989-12-14	1993-06-18	Ubaldo Conte	Compresse a rilascio a velocita' controllata delle sostanze attive
JPH0436237A (ja) *	1990-06-01	1992-02-06	Taiho Yakuhin Kogyo Kk	抗腫瘍性複合製剤
ATE137404T1 (de) *	1990-08-21	1996-05-15	Theratech Inc	Zusammensetzungen zur kontrollierten freigabe
EP0558679A1 (en) *	1990-11-24	1993-09-08	BEECHAM GROUP plc	Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
WO1992019226A1 (en) *	1991-05-07	1992-11-12	Dynagen, Inc.	A controlled, sustained release delivery system for treating drug dependency
JPH05139964A (ja) *	1991-11-14	1993-06-08	Takada Seiyaku Kk	塩酸メキシレチン腸溶性製剤
DE69429710T2 (de) *	1993-11-23	2002-08-08	Euro-Celtique S.A., Luxemburg/Luxembourg	Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe
IT1274241B (it) *	1993-12-03	1997-07-15	Smithkline Beecham Farma	Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
CA2143070C (en) *	1994-02-22	2001-12-18	Pankaj Modi	Oral controlled release liquid suspension pharmaceutical formulation
GB9422154D0 (en) *	1994-11-03	1994-12-21	Euro Celtique Sa	Pharmaceutical compositions and method of producing the same
JP3768536B2 (ja) *	1995-04-03	2006-04-19	アボツト・ラボラトリーズ	低温溶融性薬物と制御放出のための添加物との均質混合物

1995
- 1995-07-20 GB GBGB9514842.5A patent/GB9514842D0/en active Pending
1996
- 1996-07-17 DZ DZ960118A patent/DZ2074A1/fr active
- 1996-07-18 MY MYPI96002956A patent/MY141373A/en unknown
- 1996-07-18 AR ARP960103639A patent/AR003463A1/es not_active Application Discontinuation
- 1996-07-18 EG EG68296A patent/EG23934A/xx active
- 1996-07-18 MA MA24317A patent/MA23942A1/fr unknown
- 1996-07-19 AU AU66591/96A patent/AU6659196A/en not_active Abandoned
- 1996-07-19 PT PT96926388T patent/PT839039E/pt unknown
- 1996-07-19 UY UY24288A patent/UY24288A1/es not_active IP Right Cessation
- 1996-07-19 RO RO98-00082A patent/RO119119B1/ro unknown
- 1996-07-19 DE DE69630603T patent/DE69630603T3/de not_active Expired - Lifetime
- 1996-07-19 EA EA200100022A patent/EA003508B1/ru not_active IP Right Cessation
- 1996-07-19 AP APAP/P/1998/001177A patent/AP1052A/en active
- 1996-07-19 CN CNB031490468A patent/CN1282456C/zh not_active Expired - Lifetime
- 1996-07-19 KR KR10-1998-0700380A patent/KR100468351B1/ko not_active Expired - Lifetime
- 1996-07-19 PE PE1996000548A patent/PE16098A1/es not_active IP Right Cessation
- 1996-07-19 PL PL96324553A patent/PL184987B1/pl unknown
- 1996-07-19 EP EP96926388A patent/EP0839039B2/en not_active Expired - Lifetime
- 1996-07-19 UA UA98010283A patent/UA68328C2/uk unknown
- 1996-07-19 IL IL12294096A patent/IL122940A0/xx not_active IP Right Cessation
- 1996-07-19 CA CA002227298A patent/CA2227298C/en not_active Expired - Lifetime
- 1996-07-19 ZA ZA9606148A patent/ZA966148B/xx unknown
- 1996-07-19 CZ CZ1998183A patent/CZ294110B6/cs not_active IP Right Cessation
- 1996-07-19 SK SK53-98A patent/SK284117B6/sk not_active IP Right Cessation
- 1996-07-19 MX MX9800571A patent/MX9800571A/es active IP Right Grant
- 1996-07-19 HU HU9900299A patent/HU228853B1/hu unknown
- 1996-07-19 CN CN96196819A patent/CN1117567C/zh not_active Expired - Lifetime
- 1996-07-19 WO PCT/EP1996/003252 patent/WO1997003670A1/en not_active Ceased
- 1996-07-19 EA EA199800140A patent/EA003775B1/ru not_active IP Right Cessation
- 1996-07-19 DK DK96926388T patent/DK0839039T4/da active
- 1996-07-19 EP EP03078259A patent/EP1382337A1/en not_active Withdrawn
- 1996-07-19 ES ES96926388T patent/ES2208757T5/es not_active Expired - Lifetime
- 1996-07-19 JP JP50632597A patent/JP3922392B2/ja not_active Expired - Lifetime
- 1996-07-19 BR BR9609857A patent/BR9609857A/pt not_active Application Discontinuation
- 1996-07-19 AT AT96926388T patent/ATE253361T1/de active
- 1996-07-19 CA CA002445678A patent/CA2445678C/en not_active Expired - Lifetime
- 1996-07-19 SI SI9630661T patent/SI0839039T2/sl unknown
- 1996-07-19 TR TR1998/00077T patent/TR199800077T1/xx unknown
- 1996-07-19 TW TW085108758A patent/TW464513B/zh not_active IP Right Cessation
- 1996-07-19 NZ NZ315006A patent/NZ315006A/xx not_active IP Right Cessation
1997
- 1997-01-10 UY UY24436A patent/UY24436A1/es not_active IP Right Cessation
1998
- 1998-01-19 NO NO19980240A patent/NO315637B1/no not_active IP Right Cessation
- 1998-01-20 OA OA9800005A patent/OA10652A/en unknown
- 1998-02-17 BG BG102259A patent/BG64076B1/bg unknown
2000
- 2000-07-13 UY UY26242A patent/UY26242A1/es not_active Application Discontinuation
2004
- 2004-03-15 CY CY0400019A patent/CY2408B1/xx unknown
2006
- 2006-04-27 JP JP2006123731A patent/JP2006265258A/ja active Pending

Also Published As

Publication number	Publication date
UY24436A1 (es)	2001-08-27
MX9800571A (es)	1998-04-30
EP0839039B1 (en)	2003-11-05
KR19990029076A (ko)	1999-04-15
SK5398A3 (en)	1998-07-08
SI0839039T2 (sl)	2007-10-31
AR003463A1 (es)	1998-08-05
EA199800140A1 (ru)	1998-10-29
KR100468351B1 (ko)	2005-03-16
CN1195986A (zh)	1998-10-14
EA003508B1 (ru)	2003-06-26
CA2227298A1 (en)	1997-02-06
EA200100022A1 (ru)	2001-06-25
HK1010494A1 (en)	1999-06-25
PL324553A1 (en)	1998-06-08
NO315637B1 (no)	2003-10-06
AP9801177A0 (en)	1998-01-31
AP1052A (en)	2002-03-21
CZ18398A3 (cs)	1998-06-17
CA2227298C (en)	2003-12-09
OA10652A (en)	2002-09-18
IL122940A0 (en)	1998-08-16
NO980240L (no)	1998-01-20
TR199800077T1 (xx)	1998-05-21
DE69630603T3 (de)	2008-01-03
DK0839039T4 (da)	2007-10-08
AU6659196A (en)	1997-02-18
CN1117567C (zh)	2003-08-13
BG64076B1 (bg)	2003-12-31
NZ315006A (en)	2000-01-28
DE69630603D1 (de)	2003-12-11
PL184987B1 (pl)	2003-01-31
SK284117B6 (sk)	2004-09-08
UA68328C2 (en)	2004-08-16
NO980240D0 (no)	1998-01-19
SI0839039T1 (en)	2004-04-30
MA23942A1 (fr)	1997-04-01
JP2006265258A (ja)	2006-10-05
HUP9900299A3 (en)	1999-11-29
MY141373A (en)	2010-04-16
ES2208757T5 (es)	2007-12-16
CN1282456C (zh)	2006-11-01
EP0839039A1 (en)	1998-05-06
DK0839039T3 (da)	2004-03-08
ZA966148B (en)	1998-01-19
CZ294110B6 (cs)	2004-10-13
PE16098A1 (es)	1998-04-16
DZ2074A1 (fr)	2002-07-22
EA003775B1 (ru)	2003-08-28
EP0839039B2 (en)	2007-06-06
DE69630603T2 (de)	2004-09-23
EG23934A (en)	2008-01-14
CA2445678A1 (en)	1997-02-06
CY2408B1 (en)	2004-09-10
ES2208757T3 (es)	2004-06-16
BG102259A (en)	1998-09-30
GB9514842D0 (en)	1995-09-20
WO1997003670A1 (en)	1997-02-06
UY26242A1 (es)	2001-01-31
HU228853B1 (en)	2013-06-28
ATE253361T1 (de)	2003-11-15
HUP9900299A2 (hu)	1999-09-28
CN1515257A (zh)	2004-07-28
PT839039E (pt)	2004-03-31
CA2445678C (en)	2009-11-24
JPH11509539A (ja)	1999-08-24
TW464513B (en)	2001-11-21
EP1382337A1 (en)	2004-01-21
UY24288A1 (es)	1997-01-16
RO119119B1 (ro)	2004-04-30
JP3922392B2 (ja)	2007-05-30

Publication	Publication Date	Title
BR9609857A (pt)	1999-03-16	Composições de paroxetina de liberação controlada
FI974241A0 (fi)	1997-11-14	BPM-15 -koostumukset
IS4706A (is)	1998-03-31	Lyfjasamsetningar
NO962606L (no)	1996-12-23	Farmasöytisk sammensetning
DE69626556D1 (de)	2003-04-17	Biozide Zusammensetzungen
DE69610553D1 (de)	2000-11-09	Deodorant zusammensetzungen
BR9606809A (pt)	1997-12-30	Composição inseticidamente ativa
BR9607058A (pt)	1998-12-15	Composição
DE69617029D1 (de)	2001-12-20	Organoton-zusammensetzungen
NO981568D0 (no)	1998-04-06	Randtennings-tennsatssammensetninger
PT728814E (pt)	2002-09-30	Composicao betuminosa
FI963868A7 (fi)	1996-11-27	Bitumikoostumuksia
NO993460D0 (no)	1999-07-14	Paroxetine-preparater
BR9609903A (pt)	1999-05-25	ComposiçÃo inseticidamente ativa
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
DE69603228D1 (de)	1999-08-19	Aluminoxanate-Zusammensetzungen
DE69616374D1 (de)	2001-11-29	Germizide zusammensetzung
BR9606974A (pt)	1997-11-04	Composições orais
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
BR9607946A (pt)	1998-06-02	Composição
NO980595D0 (no)	1998-02-11	Biocidale sammensetninger
ATE206150T1 (de)	2001-10-15	Farbstoffstabilisierte zusammensetzungen
EE9800168A (et)	1998-12-15	Tahked kompositsioonid
BR9605777A (pt)	1998-08-25	Composição farmacêutica
EP0757075A3 (en)	1997-09-17	Polyaminotriazine composition

Legal Events

Date	Code	Title	Description
2006-01-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2006-09-19	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PEDIDO DE PATENTE COM BASE NOS ARTIGOS 8 E 13 DA LPI NO 9.279 DE 14/05/1996.
2007-07-17	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2018-03-27	B15K	Others concerning applications: alteration of classification	Ipc: A61K 31/4525 (2006.01), A61K 9/20 (2006.0